Expand Within Oncology

Standardize Closed-Loop Patient Management Across Cancer Programs

Many organizations begin with a focused oncology deployment — often lung.

Closed-loop patient management should not vary by diagnosis or facility.

Enterprise oncology expansion ensures consistent workflows across:

Breast Pancreas Complex GI GYN Liver Hematologic malignancies Screening programs aligned to oncology care pathways

Why Program-Level Variability Creates Risk

Without standardization:

  • Timeliness differs across cancer programs
  • Navigation models vary by facility
  • Registry backlogs accumulate unevenly
  • Multidisciplinary processes are inconsistent

Enterprise expansion eliminates variability and aligns performance across oncology programs.

Physician leadership discussing program standardization

Standardize Incidental Findings Across the Enterprise

Many health systems begin with lung incidental findings.

Imaging-driven findings extend beyond a single program.

Pancreatic cysts, liver lesions, complex GI findings, and structured screening follow-up require the same disciplined coordination.

Without standardized surveillance:

Enterprise expansion enables incidental findings workflows to be standardized across programs and facilities — ensuring every imaging-driven finding enters a closed-loop pathway.

This transforms incidental findings from a local program into enterprise imaging and structured follow-up infrastructure.

▶ View Incidental Findings Expansion Brief

What Oncology Expansion Delivers

  • Standardized intake workflows
  • Consistent navigator prioritization
  • Unified tumor board preparation
  • Cross-site dashboards
  • Predictable timeliness metrics

Closed-loop oncology becomes an enterprise standard — not a local program.

▶ View Oncology Expansion Executive Brief
Clinical team reviewing imaging data for oncology coordination

Standardize Oncology Across Your Enterprise

Evaluate activation opportunities across cancer programs and facilities.